(Total Views: 168)
Posted On: 01/09/2024 12:45:49 PM
Post# of 88

$SLS News Article - SELLAS Life Sciences Receives FDA Fast Track Designation for SLS009 for Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Provides Updated Data for Phase 2a Study of SLS009 in Relapsed/Refractory Acute Myeloid Leukemia Patients https://marketwirenews.com/news-releases/sell...28865.html


My Twitter: WhyteStocks